175 related articles for article (PubMed ID: 23379301)
1. Theranostics: are we there yet?
Svenson S
Mol Pharm; 2013 Mar; 10(3):848-56. PubMed ID: 23379301
[TBL] [Abstract][Full Text] [Related]
2. Supramolecular nanodevices: from design validation to theranostic nanomedicine.
Cabral H; Nishiyama N; Kataoka K
Acc Chem Res; 2011 Oct; 44(10):999-1008. PubMed ID: 21755933
[TBL] [Abstract][Full Text] [Related]
3. [Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry].
Szebeni J
Neuropsychopharmacol Hung; 2011 Mar; 13(1):15-24. PubMed ID: 21451188
[TBL] [Abstract][Full Text] [Related]
4. Organic nanocarriers for cancer drug delivery.
López-Dávila V; Seifalian AM; Loizidou M
Curr Opin Pharmacol; 2012 Aug; 12(4):414-9. PubMed ID: 22465543
[TBL] [Abstract][Full Text] [Related]
5. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
[TBL] [Abstract][Full Text] [Related]
6. What nanomedicine in the clinic right now really forms nanoparticles?
Svenson S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):125-35. PubMed ID: 24415653
[TBL] [Abstract][Full Text] [Related]
7. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
Al-Jamal WT; Kostarelos K
Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
[TBL] [Abstract][Full Text] [Related]
8. Theranostic Aspects: Treatment of Cancer by Nanotechnology.
Sarkar B; Paira P
Mini Rev Med Chem; 2018; 18(11):969-975. PubMed ID: 29189149
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic delivery.
Abeylath SC; Ganta S; Iyer AK; Amiji M
Acc Chem Res; 2011 Oct; 44(10):1009-17. PubMed ID: 21761902
[TBL] [Abstract][Full Text] [Related]
10. The dendrimer paradox--high medical expectations but poor clinical translation.
Svenson S
Chem Soc Rev; 2015 Jun; 44(12):4131-44. PubMed ID: 25971933
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional nanocarriers.
Torchilin VP
Adv Drug Deliv Rev; 2006 Dec; 58(14):1532-55. PubMed ID: 17092599
[TBL] [Abstract][Full Text] [Related]
12. Polymeric nanomedicines as a promising vehicle for solid tumor therapy and targeting.
Gupta M; Agrawal GP; Vyas SP
Curr Mol Med; 2013 Jan; 13(1):179-204. PubMed ID: 22834834
[TBL] [Abstract][Full Text] [Related]
13. Theranostic magnetic nanoparticles.
Yoo D; Lee JH; Shin TH; Cheon J
Acc Chem Res; 2011 Oct; 44(10):863-74. PubMed ID: 21823593
[TBL] [Abstract][Full Text] [Related]
14. Voyage of theranostic liposomes for imaging and therapy.
Sachin M; Sachin D; Dinesh S
J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
[TBL] [Abstract][Full Text] [Related]
15. Immunomicelles for advancing personalized therapy.
Sawant RR; Jhaveri AM; Torchilin VP
Adv Drug Deliv Rev; 2012 Oct; 64(13):1436-46. PubMed ID: 22917778
[TBL] [Abstract][Full Text] [Related]
16. Theranostic nanoparticles engineered for clinic and pharmaceutics.
Ma X; Zhao Y; Liang XJ
Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
[TBL] [Abstract][Full Text] [Related]
17. Liposomal Nanotechnology for Cancer Theranostics.
Yue X; Dai Z
Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
[TBL] [Abstract][Full Text] [Related]
18. Anticancer drug delivery with nanoparticles.
Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
[TBL] [Abstract][Full Text] [Related]
19. Nanocarriers as an emerging platform for cancer therapy.
Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
[TBL] [Abstract][Full Text] [Related]
20. Receptor-targeted nanocarriers for therapeutic delivery to cancer.
Yu B; Tai HC; Xue W; Lee LJ; Lee RJ
Mol Membr Biol; 2010 Oct; 27(7):286-98. PubMed ID: 21028937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]